Position in ATYR
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$3,885,144
-$174,758 QoQ
Shares Held
4,961,871
-11.9% QoQ
Ownership
5.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 13.085386540681931.ToString("F0")%
None 86.91461345931806.ToString("F0")%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,756,184 across 450 Biotechnology names. ATYR ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in ATYR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3,885,144 | 4,961,871 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,059,902 | 5,630,935 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $23,601,092 | 4,655,048 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $12,100,339 | 4,006,735 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $13,049,835 | 3,604,927 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,258,136 | 2,987,578 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,137,364 | 2,652,157 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,171,705 | 2,652,157 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,339,520 | 2,368,454 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $3,608,096 | 2,283,606 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $4,969,541 | 2,300,714 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,397,939 | 2,094,257 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $2,496,875 | 1,140,126 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,418,599 | 1,139,533 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,224,877 | 1,139,533 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,096,500 | 1,139,533 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,315,536 | 1,113,191 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,233,207 | 906,741 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,904,584 | 595,202 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,313,216 | 295,105 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $970,569 | 250,147 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $755,334 | 233,850 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $985,404 | 221,938 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $621,426 | 221,938 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||